首页> 外文期刊>Gynecologic Oncology Reports >Adverse post-operative outcomes in Jehovah's witnesses with gynecologic cancer within 30days of surgery: A single institution review of 36 cases
【24h】

Adverse post-operative outcomes in Jehovah's witnesses with gynecologic cancer within 30days of surgery: A single institution review of 36 cases

机译:耶和华见证人妇科手术后30天内的不良术后预后:单机构回顾36例

获取原文
           

摘要

Rates of blood transfusion are reported as high as 32% in women undergoing major gynecologic cancer surgery. Therefore, care of the gynecologic oncology patient who refuses blood products, such as Jehovah's witnesses, can pose a unique challenge. The objective of this study was to determine rate of adverse post-operative outcomes within 30days of surgery in Jehovah's witnesses with gynecologic cancer. This was a retrospective cohort study of Jehovah's witnesses undergoing laparotomy or minimally invasive surgery (MIS) for gynecologic cancer at a single institution. Data for post-adverse complications within 30days of surgery were recorded. In total, 36 patients were included with a median age of 58.5years (32–85years). The majority had endometrial adenocarcinoma ( n =23; 63.9%) or epithelial ovarian, fallopian tube or peritoneal cancer (EOC) ( n =8; 22.2%). 61.1% ( n =22) of patients underwent laparotomy and 38.9% ( n =14) had MIS procedures. 31.8% of laparotomies ( n =7) were terminated prematurely due to surgeon concern for ongoing blood loss. In patients with advanced stage EOC, the rate of suboptimal cytoreduction (>1cm) was 50%. In the laparotomy cohort, there were four (18.2%) ICU admissions and two (9.1%) mortalities. The time to adjuvant chemotherapy or radiation was 45.5days (31–64) for laparotomy compared to 35.0days (12–64) for MIS. While the majority of patients (97.2%) were unwilling to accept packed red blood cells, over one third (38.9%) were agreeable to autologous blood transfusion. Additionally, five (13.9%) patients were accepting of fresh frozen plasma, six (16.7%) patients were agreeable to cryoprecipitate and seven (19.4%) patients were willing to accept platelet transfusions. There is a high rate of postoperative adverse outcomes among Jehovah's witnesses undergoing laparotomy for gynecologic malignancy compared. Acceptance of blood products is low among Jehovah's witnesses, even in the setting of major oncologic surgery. Highlights ? Rate of adverse perioperative outcomes is high in Jehovah's witnesses. ? Laparotomy is associated with higher mortality and ICU admission. ? Acceptance of blood products is low in Jehovah's witnesses with gynecologic cancer. ? Patients should be counseled on risks of blood product refusal prior to surgery.
机译:据报道,接受大妇科癌症手术的女性的输血率高达32%。因此,拒绝血液制品的妇科肿瘤患者(例如耶和华见证人)的护理可能会带来独特的挑战。这项研究的目的是确定耶和华见证人妇科手术患者在手术后30天内的不良术后结果发生率。这是一项针对耶和华见证人在一家机构进行剖腹手术或微创手术(MIS)的妇科癌症回顾性队列研究。记录手术后30天内不良后并发症的数据。总共纳入了36名患者,中位年龄为58.5岁(32-85岁)。大多数患有子宫内膜腺癌(n = 23; 63.9%)或上皮性卵巢癌,输卵管或腹膜癌(EOC)(n = 8; 22.2%)。 61.1%(n = 22)的患者接受了剖腹手术,38.9%(n = 14)的患者进行了MIS手术。 31.8%的开腹手术(n = 7)因外科医生担心持续失血而提前终止。在晚期EOC患者中,次佳的细胞减少率(> 1cm)为50%。在剖腹手术队列中,有4例(18.2%)ICU入院率和2例(9.1%)死亡率。开腹手术的辅助化疗或放疗时间为45.5天(31-64),而MIS则为35.0天(12-64)。尽管大多数患者(97.2%)不愿接受堆积的红细胞,但超过三分之一(38.9%)的患者同意自体输血。此外,五名(13.9%)患者接受新鲜的冷冻血浆,六名(16.7%)患者同意进行冷沉淀,七名(19.4%)患者愿意接受血小板输注。相比之下,耶和华见证人因妇科恶性肿瘤而开腹手术的术后不良反应发生率较高。耶和华见证人对血液制品的接受程度很低,即使在进行大肿瘤手术的情况下也是如此。强调 ?耶和华见证人的围手术期不良结局率很高。 ?开腹手术与更高的死亡率和入住ICU有关。 ?耶和华见证人患有妇科癌症的证人对血液制品的接受程度很低。 ?术前应咨询患者血液制品拒绝的风险。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号